of borderline significanceP = 0.07
Conversely, exclusive nuclear FIH-1 expression was associated with a longer disease-free survival (HR = 0.43, 95% CI = 0.17–1.08), although this was of borderline significance ( P = 0.07) (Table 7 ).
Conversely, exclusive nuclear FIH-1 expression was associated with a longer disease-free survival (HR = 0.43, 95% CI = 0.17–1.08), although this was of borderline significance ( P = 0.07) (Table 7 ).
Tumours demonstrating nuclear FIH-1 expression showed a longer survival than those without nuclear expression (Figure 2c ) but this did not reach statistical significance ( P = 0.24, 95% CI = 0.53–1.17).